David Blackburn

NERA Economic Consulting, Washington, DC

Dr. Blackburn is a Director and Head of NERA’s Life Sciences Group. Dr. Blackburn's areas of expertise include antitrust and competition policy, intellectual property (IP) and econometric analysis. In his antitrust and commercial damages practices, he has assessed liability and damages in disputes related to tying, price fixing, and exclusionary conduct, among others, and has conducted merger analysis before the U.S. antitrust authorities.

J. Mark Gidley

White & Case, Washington, DC

J. Mark Gidley chairs the White & Case Global Antitrust/Competition practice, which is the only such practice to have been named Competition Group of the Year for seven years by Law360. His practice focuses on mergers and acquisitions, cartel cases, class actions, and pharmaceutical antitrust cases, with an emphasis on trying antitrust cases.

Keynote Speaker

Diana Moss

President, American Antitrust Institute, Washington, DC

Diana Moss became the President of the American Antitrust Institute in January 2015. An economist, Dr. Moss has developed and expanded AAI’s advocacy channels and strategies, and strengthened communications with enforcers, Congress, other advocacy groups, and the media. Her work spans both antitrust and regulation, with industry expertise in electricity, petroleum, agriculture, airlines, telecommunications, and healthcare.


Mike Cowie

Dechert, Washington, DC

Debbie Feinstein

Arnold & Porter, Washington, DC

Elaine Johnston

Allen & Overy, New York

Susan Jones

Gilbert + Tobin, Melbourne

Elinor Hoffmann

Deputy Bureau Chief, Office of the New York State Attorney General, New York

Brianne Kucerik

Weil, Gotshal & Manges, Washington, DC

Chuck Loughlin

Hogan Lovells, Washington, DC

Andrea Agathoklis Murino

Goodwin Procter, Washington, DC

Eric Stock

Gibson, Dunn & Crutcher, New York

Desma Polydorou

Senior Corporate Counsel, Antitrust, Pfizer, New York


13.00: Welcome lunch and registration

13.30: Chairs’ opening remarks

David Blackburn, NERA Economic Consulting, Washington, DC
J. Mark Gidley, White & Case, Washington, DC

13.45: Keynote address

Diana Moss, President, American Antitrust Institute, Washington, DC

14.15: Killer acquisitions in the pharmaceutical sector

Is current legislation doing enough to protect consumers from the effects of killer acquisitions?  This session will attempt to answer this question with an in-depth look at pipeline acquisitions, and consider whether more could be done to prevent companies from buying-out product lines which could have developed into competition.

Debbie Feinstein, Arnold & Porter, Washington, DC 

Susan Jones, Gilbert + Tobin, Melbourne
Brianne Kucerik, Weil, Gotshal & Manges, Washington, DC 
Andrea Agathoklis Murino, Goodwin Procter, Washington, DC

15.15: Coffee break

15.45: Pricing in pharmaceuticals

Increasingly, enforcement agencies are putting more pressure on pharmaceutical manufacturers to ensure their pricing is fair and transparent. As the number of states implementing pricing legislation is surging, it’s clear pricing remains a prominent issue in the pharmaceuticals industry. With focus shifting towards legislative remedies – is it enough? This session will consider whether the current methods in place to tackle pricing issues are adequate when addressing ills in the market.

J. Mark Gidley, White & Case, Washington, DC

Mike Cowie, Dechert, Washington, DC
Elinor Hoffmann, Deputy Bureau Chief, Office of the New York Attorney General, New York
Desma Polydorou, Senior Corporate Counsel, Antitrust, Pfizer, New York 

16.45: An update on pharmaceutical antitrust litigation  

This session will explore recent pharmaceutical litigation cases and how they are evolving. Our panelists will consider recent developments in litigation relating to citizen’s petitions and sham litigations, reverse payments, and class certification and the effect these may have on antitrust.

David Blackburn, NERA Economic Consulting, Washington, DC

Elaine Johnston, Allen & Overy, New York 
Chuck Loughlin, Hogan Lovells, Washington, DC
Eric Stock, Gibson, Dunn & Crutcher, New York

17.45: Chair’s closing remarks

David Blackburn, NERA Economic Consulting, Washington, DC
J. Mark Gidley, White & Case, Washington, DC

18.00 onwards: All delegates are invited to attend a drinks reception kindly hosted by White & Case


1221 Avenue of the Americas, New York, 10020-1095 United States


  • "Very good speakers and presentations." Robert Maness, Charles River Associates

  • "The topics... included the most important issues of competition law facing the pharmaceutical as bio-tech industry today." Ankur Kapoor, Constantine Cannon 

Ticket Prices

Private Practitioner
Type Price Expires
Super Early $350 17 Jan 2020
Early $450 07 Feb 2020
Standard $550 27 Feb 2020


In-house/government rate
Type Price
Standard $0